1- Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry 2015;72:136-42.
2- Pisani MA, Murphy TE, Araujo KL et al. Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med 2009;37:177-83.
3- Billioti de Gage S, Bégaud B, Bazin F et al. Benzodiazepine use and risk of dementia: prospective population based study. BMJ 2012;345:e6231.
4- Billioti de Gage S, Moride Y, Ducruet T et al. Benzodiazepine use and risk of Alzheimer’s disease: case-control study. BMJ 2014;349:g5205.
5- Imfeld P, Bodmer M, Jick SS, Meier CR. Benzodiazepine use and risk of developing Alzheimer’s disease or vascular dementia: A case-control analysis. Drug Saf 2015;38:909-19.
6- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, 1994.
7- Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf. 2004;3(5):485-93.
Etude et Pratique
Prophylaxie post-TVP : AOD pleine dose ou demi-dose ?
Recommandations
La borréliose de Lyme
Mise au point
Palpitations : orientation diagnostique
En 5 points
Obésité : suivi d’un patient sous aGLP-1